tiprankstipranks
Advertisement
Advertisement
Philip Morris: FDA MRTP Win for ZYN and Smoke-Free Momentum Support Buy Rating; $205 Price Target Maintained
PremiumRatingsPhilip Morris: FDA MRTP Win for ZYN and Smoke-Free Momentum Support Buy Rating; $205 Price Target Maintained
18d ago
Philip Morris Buy Rating Reaffirmed as FDA Backs ZYN; $209 Price Target Maintained on Smoke-Free Growth Outlook
Premium
Ratings
Philip Morris Buy Rating Reaffirmed as FDA Backs ZYN; $209 Price Target Maintained on Smoke-Free Growth Outlook
19d ago
Philip Morris gets FDA Modified Risk Tobacco Product orders for 20 ZYN products
Premium
The Fly
Philip Morris gets FDA Modified Risk Tobacco Product orders for 20 ZYN products
19d ago
Philip Morris Declares Quarterly Dividend, Emphasizing Investor Returns
PremiumCompany AnnouncementsPhilip Morris Declares Quarterly Dividend, Emphasizing Investor Returns
1M ago
Italy Slaps Philip Morris with €7M Fine for Misleading ‘Smoke-Free’ Marketing Claims
Premium
Market News
Italy Slaps Philip Morris with €7M Fine for Misleading ‘Smoke-Free’ Marketing Claims
1M ago
Philip Morris price target raised to $200 from $190 at Morgan Stanley
Premium
The Fly
Philip Morris price target raised to $200 from $190 at Morgan Stanley
2M ago
Philip Morris put volume heavy and directionally bearish
PremiumThe FlyPhilip Morris put volume heavy and directionally bearish
2M ago
Philip Morris price target raised to $209 from $200 at BofA
Premium
The Fly
Philip Morris price target raised to $209 from $200 at BofA
2M ago
Philip Morris appoints new chief financial officer
Premium
Company Announcements
Philip Morris appoints new chief financial officer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100